Finnrick, an independent testing programme, publishes 56 assays for Hebei Rimao Technology: 40 met its Purity focus threshold (at least 99.5% purity, no more than 35% dosage deviation) and 14 did not. Most recent assay 26 Jun 2026.
Hebei Rimao Technology operates from China, listed by Finnrick as "Trading". Source: Finnrick, https://www.finnrick.com/vendors/hebei-rimao-technology.
Finnrick-tested with poor results. Tested across 3 peptide products with 40 total samples.
Hebei Rimao Technology is listed as active. Finnrick Grade D. Finnrick avg score: 6.5/10 across 40 samples (3 products). Below-average quality. Exercise caution.
Hebei Rimao Technology holds independent lab grade D, assigned across 40 graded samples, average score 6.5/10. That grade comes from an independent grader's own sampling, not from PeptideAtlas, and it describes the samples that grader obtained rather than every batch sold.
No independent third-party assay is on file for Hebei Rimao Technology, and we have not yet compiled a profile of its own website. An untested vendor has not failed a test — this is an absence of evidence, not evidence against it.
| Product | Assays | Result |
|---|---|---|
| Retatrutide | 22 | 18 passed, 3 failed |
| Tirzepatide | 18 | 11 passed, 6 failed |
| BPC-157 | 6 | 3 passed, 3 failed |
| GHK-Cu | 5 | 5 passed, 0 failed |
| Tesamorelin | 5 | 3 passed, 2 failed |
Source: Finnrick, as published 2026-08-09. Pass and fail are Finnrick's classification against its own threshold, not ours.
| Status | Active |
|---|---|
| Independent lab grade | D (40 samples) |
| Average grader score | 6.5/10 |
| Vendor type | Research-use supplier |
| Satisfaction | 0.4/5 |
|---|---|
| Delivery | 4.8/5 |
| Customer service | 4.3/5 |
| Packaging | 4.8/5 |
| Ease of purchase | 4.8/5 |
| Payment | 4.8/5 |
Scored out of 5 by the same independent grader, from its own buyers rather than from this site.
Hebei Rimao Technology is listed as active and we hold 56 Finnrick assays (40 passing, 14 failing its purity threshold); an independent lab grade of D. That is evidence about the batches that were tested or published, not a guarantee about the vial you receive.
Yes. Finnrick, an independent testing programme, publishes 56 assays for Hebei Rimao Technology: 40 met its Purity focus threshold (at least 99.5% purity, no more than 35% dosage deviation) and 14 did not. Most recent assay 26 Jun 2026.
Similar vendors: SwissChems, Bfflink, Reta-Peptide, HkRoids, Zenith Jove Peptide ZJ, Shanghai Baoju, Heman Peptide HM, Allen Biotechnology Co ABC.
Popular peptides: Semaglutide, Tirzepatide, Retatrutide, BPC-157, CJC-1295, Ipamorelin.
Other reviewed vendors: Hebei Runxuchen Peptides Review, Helixis Labs Peptides Review, Heman Peptide HM Review.